GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » EV-to-EBIT

Bluemtec Co (XKRX:439580) EV-to-EBIT : 180.95 (As of May. 27, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bluemtec Co's Enterprise Value is ₩135,030 Mil. Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩746 Mil. Therefore, Bluemtec Co's EV-to-EBIT for today is 180.95.

The historical rank and industry rank for Bluemtec Co's EV-to-EBIT or its related term are showing as below:

XKRX:439580' s EV-to-EBIT Range Over the Past 10 Years
Min: -22.91   Med: -10.65   Max: 196.66
Current: 180.94

During the past 3 years, the highest EV-to-EBIT of Bluemtec Co was 196.66. The lowest was -22.91. And the median was -10.65.

XKRX:439580's EV-to-EBIT is ranked worse than
98.14% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 17.65 vs XKRX:439580: 180.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bluemtec Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩151,765 Mil. Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩746 Mil. Bluemtec Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.49%.

Bluemtec Co EV-to-EBIT Historical Data

The historical data trend for Bluemtec Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co EV-to-EBIT Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
EV-to-EBIT
- - -

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial - - - -123.48 203.37

Competitive Comparison of Bluemtec Co's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Bluemtec Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bluemtec Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bluemtec Co's EV-to-EBIT falls into.


Bluemtec Co EV-to-EBIT Calculation

Bluemtec Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=135029.962/746.247
=180.95

Bluemtec Co's current Enterprise Value is ₩135,030 Mil.
Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩746 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluemtec Co  (XKRX:439580) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bluemtec Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=746.247/151765.35
=0.49 %

Bluemtec Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩151,765 Mil.
Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩746 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluemtec Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bluemtec Co (XKRX:439580) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » EV-to-EBIT
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Website
https://www.bluemtec.co.kr
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines